Developmental changes in gamma-aminobutyric acid levels in attention-deficit/hyperactivity disorder.
- Bollmann S 1] Center for MR-Research, University Children's Hospital Zurich, Zürich, Switzerland [2] Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zürich, Switzerland [3] Zurich Center for Integrative Human Physiology, University of Zurich, Zürich, Switzerland [4] Institute for Biomedical Engineering, University of Zurich and ETH Zurich, Zürich, Switzerland [5] Centre for Advanced Imaging, University of Queensland, Brisbane, QLD, Australia.
- Ghisleni C 1] Center for MR-Research, University Children's Hospital Zurich, Zürich, Switzerland [2] Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zürich, Switzerland [3] Zurich Center for Integrative Human Physiology, University of Zurich, Zürich, Switzerland.
- Poil SS 1] Center for MR-Research, University Children's Hospital Zurich, Zürich, Switzerland [2] Zurich Center for Integrative Human Physiology, University of Zurich, Zürich, Switzerland.
- Martin E 1] Center for MR-Research, University Children's Hospital Zurich, Zürich, Switzerland [2] Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zürich, Switzerland.
- Ball J Department of Child and Adolescent Psychiatry, University of Zurich, Zürich, Switzerland.
- Eich-Höchli D Psychiatric University Hospital, Zürich, Switzerland.
- Edden RA 1] Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA [2] F. M. Kirby Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, USA.
- Klaver P 1] Center for MR-Research, University Children's Hospital Zurich, Zürich, Switzerland [2] Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zürich, Switzerland [3] Zurich Center for Integrative Human Physiology, University of Zurich, Zürich, Switzerland [4] Department of Psychology, University of Zurich, Zürich, Switzerland.
- Michels L Institute of Neuroradiology, University Hospital of Zurich, Zürich, Switzerland.
- Brandeis D 1] Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zürich, Switzerland [2] Zurich Center for Integrative Human Physiology, University of Zurich, Zürich, Switzerland [3] Department of Child and Adolescent Psychiatry, University of Zurich, Zürich, Switzerland [4] Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health Mannheim, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany.
- O'Gorman RL 1] Center for MR-Research, University Children's Hospital Zurich, Zürich, Switzerland [2] Zurich Center for Integrative Human Physiology, University of Zurich, Zürich, Switzerland [3] Pediatric Research Center, University Children's Hospital Zurich, Zürich, Switzerland.
- 2015-06-24
Published in:
- Translational psychiatry. - 2015
Adolescent
Adolescent Development
Adult
Age Factors
Attention Deficit Disorder with Hyperactivity
Brain
Case-Control Studies
Child
Child Development
Female
Frontal Lobe
Glutamic Acid
Glutamine
Gray Matter
Humans
Magnetic Resonance Spectroscopy
Male
Middle Aged
Young Adult
gamma-Aminobutyric Acid
English
While the neurobiological basis and developmental course of attention-deficit/hyperactivity disorder (ADHD) have not yet been fully established, an imbalance between inhibitory/excitatory neurotransmitters is thought to have an important role in the pathophysiology of ADHD. This study examined the changes in cerebral levels of GABA+, glutamate and glutamine in children and adults with ADHD using edited magnetic resonance spectroscopy. We studied 89 participants (16 children with ADHD, 19 control children, 16 adults with ADHD and 38 control adults) in a subcortical voxel (children and adults) and a frontal voxel (adults only). ADHD adults showed increased GABA+ levels relative to controls (P = 0.048), while ADHD children showed no difference in GABA+ in the subcortical voxel (P > 0.1), resulting in a significant age by disorder interaction (P = 0.026). Co-varying for age in an analysis of covariance model resulted in a nonsignificant age by disorder interaction (P = 0.06). Glutamine levels were increased in children with ADHD (P = 0.041), but there was no significant difference in adults (P > 0.1). Glutamate showed no difference between controls and ADHD patients but demonstrated a strong effect of age across both groups (P < 0.001). In conclusion, patients with ADHD show altered levels of GABA+ in a subcortical voxel which change with development. Further, we found increased glutamine levels in children with ADHD, but this difference normalized in adults. These observed imbalances in neurotransmitter levels are associated with ADHD symptomatology and lend new insight in the developmental trajectory and pathophysiology of ADHD.
- Language
-
- English
- Open access status
- gold
- Identifiers
-
- DOI 10.1038/tp.2015.79
- PMID 26101852
- Persistent URL
- https://folia.unifr.ch/global/documents/155142
Statistics
Document views: 16
File downloads:
- fulltext.pdf: 0